Evidence map›Paper›PMID 33066793›Full record

ArticleHarm reduction journal2020

The greater use of flavoured snus among ever-smokers versus never-smokers in Norway.

Tord Finne Vedoy, Karl Erik Lund

Abstract read
In one paragraph

Article in Harm reduction journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. The Short-term Impact of Standardised Packaging on Smoking and Snus Use in Norway.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tord Finne VedoyDepartment Alcohol, Tobacco and Drugs, Norwegian Institute of Public Health, PO Box 222, 0213, Skøyen, Oslo, Norway.
Karl Erik LundDepartment Alcohol, Tobacco and Drugs, Norwegian Institute of Public Health, PO Box 222, 0213, Skøyen, Oslo, Norway. kelu@fhi.no.ORCID 0000-0002-4015-1167

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSimilar to the debate around e-cigarettes, an increase in snus use among Norwegian adolescents has prompted debate on whether flavour options in snus should be limited. To this end, we compared use of flavoured snus among snus users with different smoking status.

methodsQuestions about flavoured snus use were included in an online omnibus study conducted from 2015 to 2019 (N = 65,445) that included 16,295 ever snus users (aged 15+). Current snus users (N = 9783) were asked "Do you usually use snus that has a flavouring (liquorice, mint, wintergreen, etc.)? Adjusted predicted probabilities and 95% confidence intervals (CI) were calculated from a logistic regression model.

resultsLess than 25% of the snus users reported never having smoked. The overall probability of using flavoured snus was .45 (95% CI .44-.46), highest among daily (.51, 95% CI .47-.54) and former daily smokers (.50, 95% CI .48-.52), and lowest among never (.41, 95% CI .39-.43) and occasional smokers without any prior history of daily smoking (.41, 95% CI .38-.44). Use of flavoured products was higher among female snus users (p = .67, 95% CI .65-.69) compared to males (p = .35, 95% CI .34-.36), highest among the youngest age group, 15-24 years (p = .58, 95% CI .56-.60) and decreased with increasing age.

conclusionRegulation that would ban or limit flavoured snus use may affect smokers-an at risk population-more than never smokers. The health authorities should be mindful of the real-world complexity governing potential harms and benefits of flavour restrictions on snus. A further assessment of flavour limitations should acknowledge that flavoured snus products also function as alternatives to cigarettes.

Indexed as

Electronic Nicotine Delivery SystemsTobacco ProductsTobacco, SmokelessAdolescentFemaleHumansInfant, NewbornMaleNorwaySmokersFlavourRegulationSmokeless tobaccoSnusTobacco

Identifiers

PMID33066793
PMCPMC7568365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.